๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Randwick
Clinical trial register · Australia

Clinical Trials in Randwick, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3331 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
3331
Studies in scope
all four open statuses
1807
Recruiting now
open to new participants
758
Lead sponsors
across recruiting studies
Top sites
Melbourne 1087 Adelaide 564 Sydney 508 Westmead 416 Clayton 409
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Children's Oncology Group15 AstraZeneca10 Nationwide Children's Hospital7 National Cancer Institute (NCI)7 Hoffmann-La Roche7
Site location
Melbourne1087 Adelaide564 Sydney508 Westmead416 Clayton409
All 397 locations
Target enrolment
to

Trials with a site in Randwick

208 of 3331 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
TITAN Trial: Reducing Phantom Limb Pain in People with Amputations
NCT06167330Phantom Limb Pain, Amputation
Neuroscience Research Australia
Not applicable
208
Randwick
2023-12-18
Active, closed
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
NCT05734105GIST
DrugsRipretinib·Sunitinib
Deciphera Pharmaceuticals, LLC
Phase 3
54
Randwick, Melbourne
2023-12-13
Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT06219941Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
DrugsL-leucovorin·Onivyde·Nanoliposomal Irinotecan·Sonesitatug Vedotin
AstraZeneca
Phase 2
226
Melbourne, Murdoch, Randwick
2023-12-13
Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
NCT06253130Advanced Solid Tumor
Eikon Therapeutics
Phase 1/2
156
Randwick, South Brisbane, Southport, Sydney, Woolloongabba, Frankston
2023-12-11
Active, closed
A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer
NCT06139406Lymphoma, Non-Hodgkin
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543
Janssen Research & Development, LLC
Phase 1
70
Heidelberg, Melbourne, Nedlands, Randwick
2023-12-06
Recruiting
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
NCT05583617Multiple Myeloma
DrugsCevostamab·Iberdomide·Tocilizumab·Lenalidomide
Hoffmann-La Roche
Phase 1/2
200
Randwick, Fitzroy
2023-11-14
Recruiting
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
NCT05319353Cytomegalovirus (CMV)
DrugMaribavir
Takeda
Phase 3
80
Randwick, Woollangabba, Parkville, Nedlands
2023-11-13
Recruiting
Nectero EAST System Clinical Study
NCT06001918Abdominal Aortic Aneurysm
Nectero Medical, Inc.
Phase 2/3
400
Randwick
2023-10-25
Recruiting
The GORE VBX FORWARD Clinical Study: A Comparison of the GOREยฎ VIABAHNยฎ VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
NCT05811364Aortoiliac Occlusive Disease, Peripheral Arterial Disease
W.L.Gore & Associates
Not applicable
244
Adelaide, Nedlands, Randwick
2023-10-17
Recruiting
A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
NCT06063681Advanced / Metastatic Solid Tumor
Drug8541A
Stingray Therapeutics
Phase 1
25
Randwick, Clayton, Frankston
2023-10-12
Recruiting
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
NCT05363397Acute Ischemic Stroke
DrugTBO-309
The Florey Institute of Neuroscience and Mental Health
Phase 2
80
Camperdown, Liverpool, New Lambton Heights, Randwick, Adelaide, Box Hill, Parkville
2023-09-27
Active, closed
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
NCT05911295Urothelial Carcinoma
DrugsDisitamab Vedotin·Keytruda·Gemcitabine·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Concord, Darlinghurst, Macquarie University, North Ryde, Randwick, Brisbane, Chermside, Herston
2023-09-22
Active, closed
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
NCT06047080Large B-Cell Lymphoma
DrugsPolatuzumab Vedotin·Glofitamab·Doxorubicin·Prednisone
Hoffmann-La Roche
Phase 3
1,130
Concord, Randwick, Douglas, Woolloongabba, Bedford Park, Hobart, Box Hill, Fitzroy
2023-09-18
Recruiting
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
NCT05325008BK Viremia, Kidney Transplant Infection, Kidney Transplant Failure and Rejection
DrugImmunoglobulin
The University of Queensland
Phase 3
280
Canberra, New Lambton Heights, Randwick, Sydney, Westmead, Brisbane, Townsville, Woolloongabba
2023-08-18
Recruiting
Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
NCT05969041Epithelial Tumors, Malignant
Myeloid Therapeutics
Phase 1
48
Darlinghurst, Randwick, Westmead, Bedford Park, Malvern, Nedlands
2023-08-02
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
NCT05785754Advanced or Metastatic Solid Tumors
DrugsDCSZ11·Tebentafusp·Doxorubicin·Pembrolizumab
DynamiCure Biotechnology
Phase 1
320
Randwick, Sydney, Buderim, Bedford Park, Woodville South, Clayton, Malvern, Nedlands
2023-06-28
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
NCT05716100Focal Onset Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
360
Camperdown, Randwick, Westmead, Melbourne
2023-05-09
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Randwick, Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
2023-04-25
Recruiting
MEKTOVIยฎ for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05286788Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
DrugBinimetinib
Nationwide Children's Hospital
Phase 2
38
Randwick, South Brisbane, Perth
2023-04-10
Recruiting
A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors
NCT05636215Locally Advanced Unresectable or Metastatic Solid Tumors
DrugIBI354
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
368
Randwick, Sydney, Sunshine Coast, Clayton
2023-04-04
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
NCT05774951Breast Cancer, Early Breast Cancer
DrugsCamizestrant·Tamoxifen·Exemestane·Anastrozole
AstraZeneca
Phase 3
4,300
Birtinya, Concord, Nedlands, Randwick, Tweed Heads, Waratah, Wendouree
2023-03-31
Active, closed
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)
NCT05667766Neoplasms, Bone Marrow Transplantation
Murdoch Childrens Research Institute
Not applicable
441
Randwick, North Adelaide, Parkville, Nedlands
2023-03-22
By invitation
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT05735483Atopic Dermatitis, Eczema
DrugLebrikizumab
Eli Lilly and Company
Phase 3
333
Randwick, Westmead, Coorparoo, Woolloongabba
2023-03-09
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugTovorafenib
Day One Biopharmaceuticals, Inc.
Phase 3
418
South Brisbane, Nedlands, North Adelaide, Parkville, Randwick, Westmead
2023-02-27
Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
NCT05503797Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Fore Biotherapeutics
Phase 2
254
New Lambton Heights, Orange, Randwick, Bedford Park, Melbourne
2023-02-21
Active, closed
A Study of Idazoxan in Healthy Participants
NCT05727189Healthy
Terran Biosciences Australia Pty Ltd
Phase 1
150
Randwick, Adelaide
2023-02-14
Active, closed
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
NCT05621317Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
Aravax Pty Ltd
Phase 2
90
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Nedlands
2023-02-09
Recruiting
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
NCT05518578Epilepsy, Seizures, Epileptic
DrugSPN-817
Supernus Pharmaceuticals, Inc.
Phase 2
60
Randwick, Sydney, Brisbane, Box Hill, Heidelberg, Melbourne, Parkville
2023-02-07
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
NCT05580562H3 K27M, Glioma
DrugDordaviprone
Jazz Pharmaceuticals
Phase 3
510
Randwick, Sydney, Herston, Hobart, Heidelberg, Nedlands
2023-01-23
Recruiting
ACTEMRAยฎ for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05233397Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
DrugTocilizumab
Nationwide Children's Hospital
Phase 2
30
Randwick, South Brisbane, Perth
2022-12-16
Recruiting
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
NCT05650229Primary Mitochondrial Disease
DrugNapazimone
Pharming Technologies B.V.
Phase 2
180
Randwick, Saint Leonards, Parkville, Nedlands
2022-12-13
Active, closed
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
NCT05668988Non-small Cell Lung Cancer
DrugsSunvozertinib·Pemetrexed·Carboplatin
Dizal Pharmaceuticals
Phase 3
324
Concord, Melbourne, Nedlands, Randwick
2022-12-13
Active, closed
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
NCT05556720HIV, Organ Transplantation, Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia
DrugSpikevax
Monash University
Phase 3
960
Darlinghurst, Randwick, Westmead, Herston, Woolloongabba, Adelaide, Clayton, Fitzroy
2022-12-01
Active, closed
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
NCT05286801Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma, Malignant Solid Neoplasm
DrugsTiragolumab·Tecentriq·Atezolizumab
National Cancer Institute (NCI)
Phase 1/2
86
Randwick, South Brisbane, Parkville
2022-11-17
Active, closed
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT05559359Atopic Dermatitis, Eczema
DrugLebrikizumab
Eli Lilly and Company
Phase 3
377
Coorparoo, Randwick, Westmead, Woolloongabba
2022-10-18
Active, closed
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
NCT05424822Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
DrugJNJ-80948543
Janssen Research & Development, LLC
Phase 1
167
Macquarie University, Melbourne, Nedlands, Randwick
2022-08-18
Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
NCT05304585Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma
DrugsDactinomycin·Vincrystine·Vincristine·Cyclophosphamide
Children's Oncology Group
Phase 3
205
Randwick, Westmead, Perth
2022-08-04
Recruiting
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
NCT05417594Advanced Solid Malignancies
DrugsPalacaparib·Datopotamab deruxtecan·Trastuzumab deruxtecan·Temozolomide
AstraZeneca
Phase 1/2
695
Darlinghurst, Melbourne, Randwick
2022-06-24
Recruiting
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
NCT05142189Non-Small Cell Lung Cancer
DrugsBNT116·Gotistobart·Cemiplimab·Osimertinib
BioNTech SE
Phase 1
320
Randwick, Sydney, Adelaide, Clayton
2022-06-17
Active, closed
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
NCT05115110Spinal Muscular Atrophy (SMA)
DrugsRO7204239·Risdiplam
Hoffmann-La Roche
Phase 2/3
97
Randwick
2022-06-02
Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
NCT05099003Malignant Glioma
DrugSelinexor
National Cancer Institute (NCI)
Phase 1/2
132
Randwick, Westmead, South Brisbane, Parkville, Perth
2022-05-31
Recruiting
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
NCT05277168Advanced Solid Tumors
DrugSHR-A1904
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
83
Gosford, Liverpool, Randwick, St Leonards, Sydney, Westmead, Southport, Frankston
2022-05-30
Recruiting
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
NCT05356741Locally Advanced or Metastatic HER2-Expressing Cancers
DrugsKeytruda·Pembrolizumab
Vir Biotechnology, Inc.
Phase 1/2
645
Melbourne, Randwick
2022-04-13
Active, closed
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646Immunoglobulin A Nephropathy
DrugSibeprenlimab
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Garran, Concord, Kogarah, Liverpool, New Lambton Heights, Randwick, Saint Leonards, Adelaide
2022-03-15
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
NCT05150691HER2-positive Advanced Solid Tumor
DrugsDB-1303/BNT323·Ritonavir·Itraconazole·Pertuzumab
DualityBio Inc.
Phase 1/2
796
Randwick, Sydney, South Brisbane, Melbourne
2022-01-31
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
NCT04870944Diffuse Midline Glioma, H3 K27-Altered, Metastatic Malignant Neoplasm in the Central Nervous System, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27-Altered
Children's Oncology Group
Phase 1/2
63
Randwick
2022-01-28
Active, closed
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
NCT05067634Partial Epilepsy
SK Life Science, Inc.
Phase 3
140
Parkville, Randwick, South Brisbane
2022-01-10
Recruiting
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
NCT04455932Hepatocellular Carcinoma, HCC
Concord Repatriation General Hospital
Not applicable
476
Camperdown, Concord, Gosford, Randwick, Westmead, Brisbane, Fitzroy, Heidelberg
2022-01
Active, closed
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
NCT05269394Alzheimers Disease, Dementia, Alzheimers Disease, Familial
DrugsE2814·Lecanemab
Washington University School of Medicine
Phase 2/3
197
Randwick, Melbourne
2021-12-22
Active, closed
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
NCT05127226Angelman Syndrome
DrugObudanersen
Ionis Pharmaceuticals, Inc.
Phase 1/2
71
Randwick
2021-12-22
Recruiting
High Dose Steroids in Children With Stroke
NCT04873583Paediatric Stroke
DrugsSolu-Medrol·Prednisolone·Methylprednisolone
Insel Gruppe AG, University Hospital Bern
Phase 3
70
Randwick, Westmead, Melbourne
2021-11-16
Active, closed
An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS
NCT05299658Amyotrophic Lateral Sclerosis
Clene Nanomedicine
Phase 2
40
Concord, Randwick
2021-11-13
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Adelaide, Camperdown, Randwick, Westmead, Southport, Bedford Park, Clayton, Fitzroy
2021-11-01
Recruiting
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
NCT03998319STEMI, Elevated IMR (>32)
DrugTenecteplase
University of Sydney
Phase 3
445
Bankstown, Camperdown, Concord, Frenchs Forest, Liverpool, New Lambton Heights, Randwick, Wollongong
2021-10-14
Active, closed
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
NCT04994132Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma
DrugsDactinomycin·Vinorelbine·Vincristine·Cyclophosphamide
Children's Oncology Group
Phase 3
113
Hunter Regional Mail Centre, Randwick, Westmead, Parkville, Perth
2021-09-14
Active, closed
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
NCT04774718ALK Fusion-positive Solid or CNS Tumors
DrugAlectinib
Hoffmann-La Roche
Phase 1/2
42
Randwick, Parkville
2021-09-14
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
DrugsKeytruda·Pembrolizumab
Medicenna Therapeutics, Inc.
Phase 1/2
115
Randwick, Sydney, Buderim, Greenslopes
2021-08-27
Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
NCT05004129Congenital Myotonic Dystrophy
DrugTideglusib
AMO Pharma Limited
Phase 2/3
76
Randwick
2021-08-23
Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2ฮฑ Related Genetic Alterations (MK-6482-015)
NCT04924075Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease, Advanced Gastrointestinal Stromal Tumor
DrugBelzutifan
Merck Sharp & Dohme LLC
Phase 2
355
Randwick, Parkville
2021-08-12
Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma
DrugsMesna·Thiotepa·Filgrastim·Pegfilgrastim
Children's Oncology Group
Phase 2
160
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2021-07-13
Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
NCT04775485Low-grade Glioma, Advanced Solid Tumor
DrugTovorafenib
Day One Biopharmaceuticals, Inc.
Phase 2
141
Brisbane, Parkville, Perth, Randwick, Westmead
2021-04-22
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
NCT04655404High Grade Glioma, Diffuse Intrinsic Pontine Glioma
DrugLarotrectinib
Nationwide Children's Hospital
Phase EARLY_PHASE1
15
Randwick, South Brisbane, Perth
2021-04-08
Recruiting
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
NCT06651580Chronic Pancreatitis, Exocrine Pancreas Carcinoma, Recurrent Acute Pancreatitis
M.D. Anderson Cancer Center
Observational
1,600
Randwick
2021-04-01
Active, closed
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT04408638Diffuse Large B-cell Lymphoma
DrugsRituxumab·Glofitamab·Tocilizumab·Obinutuzumab
Hoffmann-La Roche
Phase 3
270
Randwick, Adelaide, Clayton, Fitzroy, Melbourne, Nedlands
2021-02-23
Active, closed
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
NCT04521231B Cell Precursor Acute Lymphoblastic Leukemia
DrugBlinatumomab
Amgen
Phase 1/2
181
Randwick, Westmead, South Brisbane, Adelaide, Clayton, Heidelberg, Melbourne, Nedlands
2021-01-04
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
NCT04546399Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
DrugsHydrocortisone Sodium Succinate·Enrylaze·Calaspargase Pegol·Asparaginase Erwinia chrysanthemi
National Cancer Institute (NCI)
Phase 2
461
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2020-12-17
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
NCT04322318Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor
DrugsVincrystine·Ifosfamide·Topotecan·Vincristine
Children's Oncology Group
Phase 2
256
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2020-10-19
Active, closed
LIFE-BTK Randomized Controlled Trial
NCT04227899Critical Limb Ischemia (CLI)
Abbott Medical Devices
Not applicable
261
Randwick, Nedlands
2020-08-18
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
NCT04293562Acute Myeloid Leukemia
DrugsTherapeutic Hydrocortisone·Xospata·Enrylaze·Mylotarg
Children's Oncology Group
Phase 3
1,400
Randwick, Westmead, South Brisbane, Perth
2020-07-21
Recruiting
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
NCT03838042CNS Tumor, Solid Tumor
DrugOpdivo
University Hospital Heidelberg
Phase 1/2
91
Randwick, Westmead, Parkville, Nedlands
2020-05-26
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
DrugRepotrectinib
Turning Point Therapeutics, Inc.
Phase 1/2
75
Randwick, Westmead, South Brisbane, Nedlands
2020-03-12
Active, closed
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
NCT04262466Select Advanced Solid Tumors
DrugBrenetafusp
Immunocore Ltd
Phase 1/2
410
Randwick, Wollstonecraft, Melbourne, Nedlands
2020-02-25
Active, closed
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
NCT04042025Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III, SMA
DrugsOnasemnogene Abeparvovec-xioi·Zolgensma
Novartis Gene Therapies
Phase 3
85
Randwick
2020-02-10
Active, closed
A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
NCT03779334Muscular Atrophy, Spinal
DrugRisdiplam
Hoffmann-La Roche
Phase 2
26
Randwick
2019-08-07
Active, closed
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
NCT03794349High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma
DrugsSargramostim·Dinutuximab·Leukine·Temozolomide
Children's Oncology Group
Phase 2
94
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2019-07-08
Active, closed
First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA)
NCT05133492Abdominal Aortic Aneurysm, AAA, Dilation Aorta
Nectero Medical, Inc.
Not applicable
46
Randwick
2019-06-24
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Randwick, Westmead, Parkville, South Brisbane
2019-05-09
Active, closed
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
NCT03673501Gastrointestinal Stromal Tumors
DrugsRipretinib·Sunitinib
Deciphera Pharmaceuticals, LLC
Phase 3
453
Albury, Randwick, Woolloongabba, Kurralta Park, Melbourne
2019-02-08
Active, closed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
NCT03762850Immunoglobulin A Nephropathy
DrugsIrbesartan·Sparsentan·Dapagliflozin
Travere Therapeutics, Inc.
Phase 3
406
Concord, Gosford, Kingswood, New Lambton Heights, Randwick, St Leonards, Birtinya, Adelaide
2018-12-11
Active, closed
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
NCT03706365Prostate Cancer
DrugsAbiraterone acetate·Abemaciclib·Prednisone
Eli Lilly and Company
Phase 2/3
393
Camperdown, Kogarah, Macquarie University, Randwick, Melbourne
2018-11-26
Active, closed
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
NCT03581292Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma
DrugsVeliparib·Temozolomide
National Cancer Institute (NCI)
Phase 2
38
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2018-11-06
Active, closed
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
NCT03480776Ovarian Cancer Prevention
DrugAcetylsalicylic acid
Canadian Cancer Trials Group
Phase 2
117
Camperdown, Randwick, Westmead, Melbourne, Subiaco
2018-07-24
Active, closed
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
NCT03533582Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma
DrugsCDDP·Fluorouracil·Doxorubicin·Irinotecan
Children's Oncology Group
Phase 3
537
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2018-05-24
Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
NCT03564340Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer, Recurrent Endometrial Cancer
DrugsUbamatamab·Sarilumab·Cemiplimab·Tocilizumab
Regeneron Pharmaceuticals
Phase 1/2
890
Randwick, Melbourne
2018-05-21
Active, closed
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
NCT03530397Selected Advanced Solid Tumors
DrugsVolrustomig·Nab-paclitaxel·Pemetrexed·Paclitaxel
MedImmune LLC
Phase 1
400
Melbourne, Randwick
2018-04-24
Active, closed
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
NCT04195139Glioblastoma Multiforme
DrugsTemodal·Temodar·Opdivo·Temozolomide
University of Sydney
Phase 2
103
Campbelltown, Camperdown, Gosford, New Lambton Heights, Port Macquarie, Randwick, Saint Leonards, Wollongong
2018-02-22
Active, closed
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
NCT02922036Heart Failure
EBR Systems, Inc.
Not applicable
300
Garran, New Lambton Heights, Randwick, Wahroonga, Chermside, Adelaide, Clayton, Parkville
2018-01-17
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Albury, Camperdown, Gosford, North Ryde, Randwick, St Albans
2017-09-05
Active, closed
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
NCT03089905Anesthesia, Neurotoxicity, Child Development
DrugsUltiva·Remifentanil·Sevoflurane·Dexmedetomidine
Murdoch Childrens Research Institute
Phase 3
450
Randwick, Westmead, Brisbane, Adelaide, Bedford Park, Parkville, Perth
2017-08-10
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsIsophosphamide·L-leucovorin·Therapeutic Hydrocortisone·Levofolinate
Children's Oncology Group
Phase 3
352
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2017-08-08
Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
NCT03067181Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor
DrugsBleomycin·Etoposide·Cisplatin·Carboplatin
Children's Oncology Group
Phase 3
1,780
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2017-05-25
Active, closed
Durvalumab and Tremelimumab ยฑ Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
NCT03057106Lung Cancer Metastatic
DrugsTremelimumab·Durvalumab
Canadian Cancer Trials Group
Phase 2
301
Campbelltown, Coffs Harbour, Concord, Kingswood, Kogarah, Lismore, Liverpool, Randwick
2017-03-28
Active, closed
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
NCT03075696Non-Hodgkin's Lymphoma
DrugsGlofitamab·Tocilizumab·Obinutuzumab
Hoffmann-La Roche
Phase 1/2
940
Randwick, Melbourne
2017-02-21
Active, closed
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
NCT01320345Type 1 Diabetes Mellitus, Diabetic Retinopathy, Diabetic Nephropathies
DrugFenofibrate
University of Sydney
Phase 3
412
Garran, Camperdown, Concord, Darlinghurst, Liverpool, Merewether, Randwick, Saint Leonards
2016-11-03
Active, closed
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
NCT02567435Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Rhabdomyosarcoma
DrugsTemsirolimus·Dactinomycin·Vinorelbine·Vincristine
National Cancer Institute (NCI)
Phase 3
325
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2016-06-01
Active, closed
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
NCT02521493Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome, Myeloid Leukemia Associated With Down Syndrome
DrugsL-Asp·Leucogen·L-Asparaginase·Asparaginase
Children's Oncology Group
Phase 3
280
Hunter Regional Mail Centre, Randwick, Westmead, Parkville, Perth
2015-12-23
Recruiting
Project: Every Child for Younger Patients With Cancer
NCT02402244Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma
Children's Oncology Group
Observational
75,000
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Saint Hobart, Clayton, Parkville
2015-11-03
Active, closed
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
NCT02339740Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
DrugsTretinoin·Arsenic Trioxide·Idarubicin·Mitoxantrone
Children's Oncology Group
Phase 3
158
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2015-07-21
Active, closed
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
NCT02176967Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neuroblastoma
DrugsDoxorubicin Hydrochloride·Adriamycin·Daunorubicin·Etoposide
Children's Oncology Group
Phase 3
621
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Perth
2014-08-08
Active, closed
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
NCT02170090Cholangiocarcinoma, Gall Bladder Carcinoma
DrugsCapecitabine·Gemcitabine·Cisplatin
Universitรคtsklinikum Hamburg-Eppendorf
Phase 3
789
Bankstown, Kingswood, Kogarah, Randwick, Waratah, Douglas, Herston, Woolloongabba
2014-04
Rows per page Showing 101–200 of 208
Previous 1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-australia/city/randwick?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,331 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 208 of those studies with a site in Randwick.

How many clinical trials are recruiting in Randwick?

132 of the 208 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 4 have not yet opened recruitment, 67 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.